0001628280-22-025654.txt : 20220928
0001628280-22-025654.hdr.sgml : 20220928
20220928205012
ACCESSION NUMBER: 0001628280-22-025654
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220922
FILED AS OF DATE: 20220928
DATE AS OF CHANGE: 20220928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41477
FILM NUMBER: 221277558
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Ltd.
CENTRAL INDEX KEY: 0001935979
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
FORMER COMPANY:
FORMER CONFORMED NAME: Biohaven Research Ltd.
DATE OF NAME CHANGE: 20220629
3
1
wf-form3_166441259587540.xml
FORM 3
X0206
3
2022-09-22
0
0001935979
Biohaven Ltd.
BHVN
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
215 CHURCH STREET
NEW HAVEN
CT
06510
0
0
1
0
Common Shares
100
D
This Form 3 is being filed in connection with the Securities and Exchange Commission's declaration of effectiveness of the Registration Statement on Form 10 of Biohaven Ltd., which describes the planned distribution by Biohaven Pharmaceutical Holding Company Ltd. of all of the common shares of Biohaven Ltd.
Beginning on September 23, 2022, Issuer common shares traded on a "when-issued" basis on the New York Stock Exchange under the symbol "BHVN WI" and under "Biohaven Ltd." When-issued trading of SpinCo common shares will continue until the distribution occurs. SpinCo common shares are expected to begin "regular-way" trading on the NYSE under the symbol "BHVN" on the first trading day following the distribution date.
/s/ Vladimir Coric, Chief Executive Officer of Biohaven Pharmaceutical Holding Company Ltd.
2022-09-28